Overview

Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine

Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Randomized, cross-over, controlled, open label study. The aim of this study is to demonstrate that glucose may completely be replaced by a combination of xylitol and carnitine in the bimodal PD solution for long dwell exchange.
Phase:
Phase 2
Details
Lead Sponsor:
Iperboreal Pharma Srl
Treatments:
Dialysis Solutions
Icodextrin
Pharmaceutical Solutions